Biondo Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-23,961
Closed -$2.2M 82
2021
Q4
$2.2M Sell
23,961
-11,055
-32% -$1.32M 0.37% 47
2021
Q3
$4.44M Sell
35,016
-1,709
-5% -$249K 0.76% 43
2021
Q2
$6.11M Buy
+36,725
New +$5.95M 1.05% 35
2018
Q4
Sell
-4,250
Closed -$367K 84
2018
Q3
$367K Buy
4,250
+725
+21% +$51.7K 0.09% 72
2018
Q2
$205K Buy
+3,525
New +$172K 0.05% 80

Other funds holding TDOC

Biondo Investment Advisors's TDOC Position: Q1 2022 in Review

Biondo Investment Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 23,961 shares — an estimated $2.2M sold.

Biondo Investment Advisors first reported a position in TDOC in Q2 2018 and held it in 5 quarters. The position peaked at $6.11M in Q2 2021. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Biondo Investment Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Biondo Investment Advisors sold 23,961 Teladoc Health shares in Q1 2022, an estimated $2.2M.
  • Biondo Investment Advisors first reported a position in Teladoc Health in Q2 2018 and held it in 5 quarters.
  • Biondo Investment Advisors's Teladoc Health position peaked at $6.11M in Q2 2021.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Biondo Investment Advisors's 13F filing for Q1 2022, filed 12 May 2022.